Published on Dec 10, 2019
In our last few posts, we’ve been giving you reasons to attend Emerging Medtech Summit 2020. This industry-leading conference, hosted by Life Science Intelligence, will be held February 18th through the 20th in Dana Point, California, at The Ritz-Carlton Laguna Niguel.
We’ve already discussed three reasons you’ll want to attend: the stellar keynote from Christopher Velis, the wide-ranging panel discussions from a variety of industry leaders, and the access you’ll gain to CEOs from over 100 presenting companies.
Today we’ll discuss one more reason, one that’s the most important of all for some of our attendees: the chance to mingle with investors (or, if you’re an investor, the chance to liaise with companies seeking funding).
We understand that the medical technology field is one with massive startup and R&D costs. So do investors. At Emerging Medtech Summit 2020, you’ll rub shoulders with numerous investors that focus in the medical space. If you’re looking for a venture capital investment, you’ll want to attend this summit.
Check out a partial list of confirmed investor attendees.
Of course, if you’re an investor reading this who is interested in attending to make connections with startups, great! Let’s start a conversation today.
Perhaps you’re not looking for venture capital as much as you’re hoping to be acquired. There’s certainly space for that in this industry and at this summit. We’ll have representatives in attendance from large corporations with an eye toward M&A. If acquisition is your goal, this summit could be a fantastic opportunity to network in that space.
We have a few spots remaining for Emerging Medtech Summit 2020, but we don’t anticipate them lasting much longer. If you’re interested in attending for some part of the investment equation, don’t delay. Register yourself or your team today.
LSI's global events attract top innovators, active investors, and deal-making strategics.GET INFO
The only all-in-one market intel platform tracking the market data, companies, & deals shaping medtech.